Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis

Sarcoidosis Vasc Diffuse Lung Dis. 1996 Mar;13(1):33-7. doi: 10.1007/BF00383966.

Abstract

In order to find out whether substance P (SP) participates in the inflammatory and fibrotic processes of interstitial lung diseases or not, SP-like immunoreactive substance (SP-IS) concentrations in bronchoalveolar lavage (BAL) fluids from patients with idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis were measured using enzyme immunoassay (EIA). The mean SP-IS concentrations in BAL fluids from healthy nonsmokers and healthy smokers were 0.87 +/- 0.19 and 0.98 +/- 0.23 pg/ml, respectively. The mean SP-IS concentration in BAL fluids from patients with IPF was 1.15 +/- 0.39 pg/ml. The value of patients with IPF was significantly higher than that of healthy nonsmokers (p < 0.01). The mean SP-IS concentrations in BAL fluids from pulmonary sarcoidosis patients in stage I, stage II and stage III were 0.91 +/- 0.19, 0.96 +/- 0.35 and 1.00 +/- 0.29 pg/ml, respectively. No correlation was found between SP-IS concentration and pulmonary functions in IPF and sarcoidosis patients. The present results indicate that SP may be involved in the inflammatory process in IPF.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Bronchoalveolar Lavage Fluid / chemistry*
  • Chromatography, High Pressure Liquid
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Middle Aged
  • Pulmonary Fibrosis / complications*
  • Sarcoidosis, Pulmonary / complications*
  • Substance P / analysis*

Substances

  • Substance P